0001209191-11-033761.txt : 20110608 0001209191-11-033761.hdr.sgml : 20110607 20110608194542 ACCESSION NUMBER: 0001209191-11-033761 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110606 FILED AS OF DATE: 20110608 DATE AS OF CHANGE: 20110608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: THERAVANCE INC CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508086000 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: S. SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRAZAN JEFFREY M CENTRAL INDEX KEY: 0001032623 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 11901930 MAIL ADDRESS: STREET 1: 2884 SAND HILL RD STE 100 CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 c18503_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4 2011-06-06 0001080014 THERAVANCE INC THRX 0001032623 DRAZAN JEFFREY M BERTRAM CAPITAL 800 CONCAR DRIVE, SUITE 100 SAN MATEO CA 94402 1 0 0 0 Common Stock 2011-06-06 2011-06-06 4 S 0 37344 23.08 D 78251 D Common Stock 2011-06-07 2011-06-07 4 S 0 31907 23.29 D 46344 D Represents sales of (i) 15,000 shares held personally by the Reporting Person and (ii) 22,344 shares held by Sierra Ventures Associates VI, L.P. as nominee for the Reporting Person. Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $23.00 to $23.23 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $23.25 to $23.38 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. /s/ Jeffrey M. Drazan 2011-06-07